Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP).
R
R
Swords
D
D
Power
M
M
Fay
R
R
O'Donnell
P T
PT
Murphy
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D009894:Opportunistic Infections; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab